Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2) (BabySTEPS2)
Retinopathy of Prematurity
About this trial
This is an interventional other trial for Retinopathy of Prematurity focused on measuring Optical Coherence Tomography (OCT), Optical Coherence Tomography Angiography (OCTA), Retinopathy of Prematurity, Neurodevelopment, Visual Acuity
Eligibility Criteria
Inclusion Criteria:
- Children previously enrolled in BabySTEPS1 (Pro00069721) that have already consented to being contacted for this school age follow on study, Cohort 1 only
- Parent/Legal Guardian is able and willing to consent to study participation with follow up approximately between 4.5 and 5 years of age (consent available in Spanish* and English) (SA 1 only)
- Parent/Legal Guardian is able and willing to consent to study participation for the infant (SA 2 and 2c only)
- Infant/child undergoing clinically-indicated examination under anesthesia that may or may not have eye pathology (SA 2 only)
- Infant inborn or outborn at (SA 2 only):
- Duke Hospital (Years 1, 2 and 3) with birth weight ≤1000 grams, and/or 20 0/7 to 28/ 6/7 (<29 weeks) gestational age
- Duke Hospital (Years 1, 2 and 3) at high risk to require treatment for ROP irrespective of birth weight and gestational age (e.g. pre-plus, severe ROP in zone 1, APROP, etc.)
- Duke Regional Hospital (Years 4 and 5) that meets the American Association of Pediatrics eligibility of ROP screening (Infants with a birth weight of ≤1500 g or gestational age of 30 weeks)
- Adults (over the age of 18 years) that may or may not have eye pathology (SA 2 only)
Exclusion Criteria:
- Participant or Parent/Legal Guardian unwilling or unable to provide consent
- Adult participant or infant/child has a health or eye condition that preclude eye examination or retinal imaging (e.g. corneal opacity such as with Peter's anomaly or cataract) (SA2 only)
- Infant has a health condition, other than prematurity, that has a profound impact on brain development (e.g. anencephaly) (SA2 only)
Sites / Locations
- Duke University Eye CenterRecruiting
- University of Pennsylvania, Center for Preventive Ophthalmology and Biostatistics
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Cohort 1: Functional and structural outcomes in children after bedside OCT imaging in infancy
Cohort 2: Test of bedside OCT imaging data to predict RW-ROP or ROP progression
Cohort 3: Comparison of ROP imaging with investigational OCT versus retinal camera
Cohort 4: Adult and pediatric participants enrolled for imaging during system development
80 pediatric participants who were previously enrolled in BabySTEPS1 from July 22, 2016 - December 30, 2020 will be enrolled for follow-up neurodevelopmental testing, visual acuity, visual function testing and investigational retinal imaging
250 infants at risk for retinopathy of prematurity: 132 will be enrolled and have investigational bedside OCT retinal imaging, and their data will be combined with that from 118 infants who had similar imaging in BabySTEPS1 for analysis of the total group versus the indirect ophthalmoscopic clinical exam data.
102 infants, who are a sub-group of the 132 enrolled in Cohort 2, will also have imaging with a conventional, commercially available, retinal camera system to compare utility, stress, and prediction and documentation of referral-warranted ROP between the camera images and those from investigational OCT.
12 awake healthy adult controls and 12 pediatric participants undergoing examination under anesthesia in the operating room will be imaged with the investigational bedside OCT for the purpose of technological development.